Response to "Disparities in the Use of Chemotherapy and Monoclonal Antibody Therapy for Elderly Advanced Colorectal Cancer Patients in the Community Oncology Setting"

被引：0
|
作者：
Moore, Maggie [1 ]
Kosmider, Suzanne [1 ,2 ]
Field, Kathryn [1 ,2 ]
Desai, Jayesh [1 ,2 ]
Lim, Lionel [2 ]
Barnett, Frances [2 ]
Gibbs, Peter [1 ,2 ]
机构：
[1] Western Hosp, Dept Oncol, Footscray, Vic 3011, Australia
[2] Royal Melbourne Hosp, Dept Oncol, Parkville, Vic 3050, Australia
来源：
ONCOLOGIST | 2009年 / 14卷 / 01期
关键词：
RANDOMIZED CONTROLLED-TRIAL; COMBINATION CHEMOTHERAPY;
D O I：
10.1634/theoncologist.2008-0222
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：104 / 105
页数：2
相关论文
共 50 条
  • [21] TREATMENT PATTERNS AND OUTCOMES IN METASTATIC COLORECTAL CANCER (MCRC) PATIENTS TREATED IN A COMMUNITY ONCOLOGY SETTING
    Cartwright, T. H.
    Pan, I
    Wen, L.
    Wadlow, R. C.
    Rembert, D.
    Seal, B.
    VALUE IN HEALTH, 2014, 17 (03) : A69 - A70
  • [22] Metastatic colorectal cancer (mCRC): Recent patterns of chemotherapy and monoclonal antibody (MoAb) therapy in clinical practice
    Hess, G. P.
    Wang, P. F.
    Quach, D.
    Barber, B.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [23] Response to Neoadjuvant Chemotherapy in Elderly Patients with Locally Advanced Breast Cancer.
    Vanderhaegen, J.
    Wildiers, H.
    Christiaens, M-R
    Smeets, A.
    Leunen, K.
    Neven, P.
    Vergote, I.
    Vanlimbergen, E.
    Weitens, C.
    Janssen, H.
    Moerman, P.
    Brouckaert, O.
    Brouwers, B.
    Paridaens, R.
    CANCER RESEARCH, 2011, 71
  • [24] Treatment response in elderly patients with advanced colorectal cancer at King Abdulaziz Medical City, Princess Norah Oncology Center, Jeddah
    Leslom, Abdullah Nasser
    Alqahtani, Fahad Juwayid
    Hanash, Abdulbari Ahmed Saeed
    Alsubaie, Abdullah Abdulhadi
    Alamri, Mohammed Saeed
    JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE, 2020, 9 (02) : 898 - 903
  • [25] Systemic Therapy for Metastatic Colorectal Cancer: Patterns of Chemotherapy and Biologic Therapy Use in US Medical Oncology Practice
    Hess, Gregory P.
    Wang, Peter Feng
    Quach, David
    Barber, Beth
    Zhao, Zhongyun
    JOURNAL OF ONCOLOGY PRACTICE, 2010, 6 (06) : 301 - +
  • [26] Changing monoclonal antibody keeping unaltered the chemotherapy regimen in metastatic colorectal cancer patients: is efficacy maintained?
    Grande, Roberta
    Gemma, Donatello
    Sperduti, Isabella
    Gelibter, Alain
    Giampaolo, Maria Anna
    Trombetta, Giorgio
    Nelli, Fabrizio
    Gamucci, Teresa
    SPRINGERPLUS, 2013, 2 : 1 - 6
  • [27] Surgery for advanced colorectal cancer in elderly patients with special emphasis for radio-chemotherapy role
    Chiappa, Antonio
    Bertani, Emilio
    Zbar, Andrew P.
    Biffi, Roberto
    Biella, Francesca
    Bellomi, Massimo
    Zampino, Giulia
    Fazio, Nicola
    Poldi, Davide
    Page, Ugo
    Andreoni, Bruno
    HEPATO-GASTROENTEROLOGY, 2007, 54 (75) : 740 - 745
  • [28] Activity and toxicity of 6-fluorouracil based chemotherapy in elderly patients with advanced colorectal cancer
    Daniele, B
    Rosati, G
    Pignata, S
    Rossi, A
    Tambaro, R
    De Maio, E
    Ottaiano, A
    Barletta, E
    Manzione, L
    Iaffaioli, V
    Perrone, F
    GASTROENTEROLOGY, 2002, 122 (04) : A68 - A68
  • [29] Use of palliative chemotherapy and targeted agents in elderly patients with metastatic colorectal cancer (mCRC).
    Chan, Matthew
    Renouf, Daniel John
    Speers, Caroline
    Cheung, Winson Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [30] USE OF PALLIATIVE CHEMOTHERAPY AND TARGETED AGENTS IN ELDERLY PATIENTS WITH METASTATIC COLORECTAL CANCER (MCRC)
    Cheung, W. Y.
    Renouf, D.
    Lim, H.
    Kennecke, H.
    ANNALS OF ONCOLOGY, 2012, 23 : 215 - 215
12345